専門医のための精神科臨床リュミエール2　精神疾患と脳画像

出版社： 中山書店
著者：
発行日： 2008-06-10
分野： 臨床医学：内科  >  精神医学
ISBN： 9784521730240
シリーズ： 専門医のための精神科臨床リュミエール
電子書籍版： 2008-06-10 （初版第1刷）
書籍・雑誌
≪全国送料無料でお届け≫
取寄せ目安：8～14営業日

7,590 円(税込)

購入する
電子書籍
章別単位での購入はできません
ブラウザ、アプリ閲覧

7,590 円(税込)

購入する

商品紹介

実地の精神科医療に携わる専門医が、大学病院等で撮像された脳画像から精神疾患をどのように読み取ればよいか、具体的な症例を中心に紹介した実践の書。治療の場において、必要な検査を効率よく行うための、各検査の基礎知識や原理、特性についても解説。

目次

  • 専門医のための精神科臨床リュミエール2　精神疾患と脳画像

    ―目次―

    1．検査の実際とデータの意義
    　1．MRI
    　2．fMRI
    3. PET、SPECT
    　4．NIRS

    2．精神疾患におけるトピック
    　1．統合失調症の脳構造
    　2．統合失調症の社会的認知と脳構造
    　3．悪性腫瘍と気分障害
    　4．PTSD
    　5．強迫性障害
    　6．パニック障害
    　7．摂食障害
    　8．薬物・アルコール関連障害
    　9．精神科医による認知症画像診断
    　10．広汎性発達障害、AD/HD
    　11．器質性精神障害
    　12．神経伝達物質受容体の画像化
    　13．脳構造と遺伝子

    3．脳画像検査の実用化
    　1．統合失調症の脳構造診断の実用化
    　2．気分障害の脳画像と死後脳解析の臨床的意義
    　3．Alzheimer病のSPECT診断　
    　4．NIRS検査による精神疾患の診断

この書籍の参考文献

参考文献のリンクは、リンク先の都合等により正しく表示されない場合がありますので、あらかじめご了承下さい。

本参考文献は電子書籍掲載内容を元にしております。

I 検査の実際とデータの意義

P.19 掲載の参考文献
1) 片山仁, ほか. MRI のABC. 日本医師会雑誌特別号 1999 ; 121 (12).
 
2) 成瀬昭二, 田中忠蔵. 拡散強調画像の可能性. 最新医学 2005 ; 60 (5) : 952-964.
Medical*Online
3) 宮内哲, 三崎将也. 機能的磁気共鳴画像の計測と解析. 最新医学 2005 ; 60 (5) : 1025-1035.
Medical*Online
4) 松田博史. MRI標準データベースを使用したアルツハイマー型痴呆の早期診断を考える. 老年精神医学雑誌 2005 ; 16 : 38-44.
Medical*Online
鬼塚俊明. sMRI-ROI. 平安良雄, ほか (編). 精神疾患の脳画像解析・診断学. 東京 : 南山堂 ; 印刷中.
 
P.32 掲載の参考文献
1) Talairach J, Tournoux P. Co-Planar Stereotaxic Atlas of the Human Brain : 3-Dimensional Proportional System : An Approach to Cerebral Imaging. New York : Thieme ; 1988.
 
2) Aleman A, Kahn RS. Strange feelings : Do amygdala abnormalities dysregulate the emotional brain in schizophrenia? Prog Neurobiol 2005 ; 77 (5) :283-298.
PubMed
3) 切原賢治, ほか. 統合失調症における精神生理学的および神経画像にもとづいたエンドフェノタイプ. 分子精神医学 2005 ; 5 : 113-125.
Medical*Online
4) 小林伸久, 加藤元一郎, ヘイフト典子. 精神神経疾患の転帰はニューロイメージングに予測可能か? BRAIN and NERVE 2007 ; 59 (10) : 1203-1210.
 
5) 岡田 剛, 岡本泰昌, 山脇成人. Functional MRI うつ病の補助診断法としての可能性. 精神医学 2007 ; 49 (3) : 285-291.
 
6) 小早川英夫, 萬谷智之, 岡本泰昌. 気分障害における小脳の役割. 分子精神医学 2007 ; 7 (1) : 14-20.
Medical*Online
7) Mitterschiffthaler MT, et al. Applications of functional magnetic resonance imaging in psychiatry. J Magn Reson Imaging 2006 ; 23 (6) :851-861.
 
8) Dapretto M, et al. Understanding emotions in others : Mirror neuron dysfunction in children with autism spectrum disorders. Nat Neurosci 2006 ; 9 (1) : 28-30.
PubMed
9) Baron-Cohen S, et al. fMRI of parents of children with Asperger Syndrome : A pilot study. Brain Cogn 2006 ; 61 (1) : 122-130.
PubMed
10) Dickerson BC. Advances in functional magnetic resonance imaging : Technology and clinical applications. Neurotherapeutics 2007 ; 4 (3) : 360-370.
PubMed
小坂浩隆, 大森晶夫, 和田有司. 統合失調症のfMRI研究の動向. Schizophrenia Frontier 2005 ; 6 (4) : 267-274.
Medical*Online
大森晶夫, 小坂浩隆, 和田有司. fuctional MRIによる高次脳機能評価 (1) -基礎と臨床応用. 臨床脳波 2005 ; 47 (1) : 54-61.
 
大森晶夫, 小坂浩隆, 和田有司. fuctional MRIによる高次脳機能評価 (2) -認知機能と精神疾患研究. 臨床脳波 2005 ; 47 (2) : 127-134.
 
特集 : 精神科疾患の脳画像解析の最新知見. 精神科 2006 ; 9 (3) : 193-235.
 
特集 : 神経症圏障害のすべて. 臨床精神医学 2006 ; 35 (6) : 603-907.
 
月本洋, ほか. 脳機能画像解析入門-SPMでfMRI, 拡散テンソルを使いこなす. 東京 : 医歯薬出版 ; 2007.
 
Sorensen AG. Future prospects for fMRI in the clinic. J Magn Reson Imaging 2006 ; 23 (6) : 941-944.
PubMed
Ragland JD, et al. Neuroimaging of cognitive disability in schizophrenia : Search for a pathophysiological mechanism. Int Rev Psychiatry 2007 ; 19 (4) : 417-427.
 
Brown GG, Eyler LT. Methodological and conceptual issues in functional magnetic resonance imaging : Applications to schizophrenia research. Annu Rev Clin Psychol 2006 ; 2 : 51-81.
PubMed
杉原玄一, ほか. アスペルガー症候群病因と臨床研究病因・病態の解明脳画像から見た病態. 日本臨床 2007 ; 65 (3) : 449-452.
 
Hughes JR. Autism : The first firm finding = underconnectivity? Epilepsy Behav 2007 ; 11 (1) : 20-24.
PubMed
Schultz RT. Developmental deficits in social perception in autism : The role of the amygdala and fusiform face area. Int J Dev Neurosci 2005 ; 23 (2-3) : 125-141.
 
P.44 掲載の参考文献
1) Logan J. Graphical analysis of PET data applied to reversible and irreversible tracers. Nucl Med Biol 2000 ; 27 : 661-670.
PubMed
2) Frith CD, et al. Principles and methods. In : Frackowiak RSJ, et al (eds). Human Brain Function,1st edition. San Diego : Academic Press ; 1997. pp3-159.
 
3) Minoshima S, et al. A diagnostic approach in Alzheimer's disease using three-dimensional stereotactic surface projections of fluorine-18-FDG PET. J Nucl Med 1995 ; 36 : 1238-1248.
 
4) Matsuda H, et al. Automated discrimination between very early Alzheimer's disease and controls using an easy Z-score imaging system for multicenter brain perfusion SPECT. AJNR Am J Neuroradiol 2007 ; 28 : 731-736.
PubMed
日本放射線技術学会 (編). 放射線技術学シリーズ, 核医学検査技術学, 改訂第2版. 東京 : オーム社 ; 2008.
 
松田博史, 朝田 隆 (編). 見て診て学ぶ痴呆の画像診断. 大阪 : 永井書店 ; 2004.
 
P.55 掲載の参考文献
1) Jobsis FF. Non-invasive infrared monitoring of cerebral and myocardial oxygen sufficiency and circulatory parameters. Science 1977 ; 198 : 1264-1267.
 
2) 福田正人, ほか. 精神疾患の生理学におけるNIRSの意義. 臨床精神医学 2004 ; 33 : 787-798.
Medical*Online
3) Suto T, et al. Multichannel near-infrared spectroscopy in depression and schizophrenia : Cognitive activation study. Biol Psychiatry 2004 ; 55 : 501-511.
PubMed
4) Takizawa R, et al. Reduced frontopolar activation during verbal fluency task in schizophrenia : A multi-channel near-infrared spectroscopy study. Schizophr Res 2008 ; 99 : 250-262.
PubMed
5) Kameyama M, et al. Sex and age dependencies of cerebral blood volume changes during cognitive activation : A multichannel near-infrared spectroscopy. Neuroimage 2004 ; 22 : 1715-1721.
PubMed
6) 福田正人, 三國雅彦. 心の健康に光トポグラフィー検査を応用する会. 近赤外線スペクトロスコピーNIRSによる統合失調症と感情障害の補助診断. 精神医学 2007 ; 49 : 231-243.
 
Boas DA, Dale AM, Franceschini MA. Diffuse optical imaging of brain activation : Approaches to optimizing image sensitivity, resolution, and accuracy. Neuroimage 2004 ; 23 (Suppl 1) : S275-288.
 
Hoshi Y. Functional near-infrared optical imaging : Utility and limitation in human brain mapping. Psychophysiology 2003 ; 40 : 511-520.
PubMed
Obrig H, Villringer A. Beyond the visible : Imaging the human brain with light. J Cereb Blood Flow Metab 2003 ; 23 : 1-18.
 
Strangman G, Boas DA, Sutton JP. Non-invasive neuroimaging using near-infrared light. Biol Psychiatry 2002 ; 52 : 679-693.
PubMed
Wolf M, Ferrari M, Quaresima V. Progress of near-infrared spectroscopy and topography for brain and muscle applications. J Biomed Opt 2007 ; 12 : 062104.
PubMed

II 精神疾患におけるトピック

P.68 掲載の参考文献
1) Yamasue H, et al. Localized volume reduction in prefrontal, temporolimbic, and paralimbic regions in schizophrenia : An MRI parcellation study. Psychiatry Res 2004 ; 131 : 195-207.
PubMed
2) Davidson LL, Heinrichs RW. Quantification of frontal and temporal lobe brain-imaging findings in schizophrenia : A meta-analysis. Psychiatry Res 2003 ; 122 : 69-87.
PubMed
3) Kubicki M, et al. Voxel-based morphometric analysis of gray matter in first episode schizophrenia. Neuroimage 2002 ; 17 : 1711-1719.
PubMed
4) Honea R, et al. Regional deficits in brain volume in schizophrenia : A meta-analysis of voxelbased morphometry studies. Am J Psychiatry 2005 ; 162 : 2233-2245.
PubMed
5) 武井邦夫, 山末英典, 笠井清登. 認知機能障害の病態機序-画像診断・神経生理検査からの評価. 臨床精神薬理 2007 ; 10 : 1161-1167.
 
6) Yamasaki S, et al. Reduced planum temporale volume and delusional behavior in patients with schizophrenia. Eur Arch Psychiatry Clin Neurosci 2007 ; 257 : 318-324.
PubMed
7) Cannon TD, et al. Cortex mapping reveals regionally specific patterns of genetic and diseasespecific gray-matter deficits in twins discordant for schizophrenia. Proc Natl Acad Sci U S A 2002 ; 99 : 3228-3233.
PubMed
8) 井上秀之, ほか. 神経画像を中間表現型として用いた遺伝子多型との関連解析 : BDNF Val66Met 多型と桃体・海馬の体積は日本人において関連しない. 精神薬療基金研究年報 2006 ; 38 : 99-104.
 
9) Kasai K, et al. Progressive decrease of left superior temporal gyrus gray matter volume in patients with first-episode schizophrenia. Am J Psychiatry 2003 ; 160 : 156-164.
PubMed
10) Thompson PM, et al. Mapping adolescent brain change reveals dynamic wave of accelerated gray matter loss in very early-onset schizophrenia. Proc Natl Acad Sci U S A 2001 ; 98 : 11650-11655.
PubMed
11) Pantelis C, et al. Neuroanatomical abnormalities before and after onset of psychosis : A crosssectional and longitudinal MRI comparison. Lancet 2003 ; 361 : 281-288.
PubMed
12) Job DE, et al. Grey matter changes over time in high risk subjects developing schizophrenia. Neuroimage 2005 ; 25 : 1023-1030.
PubMed
13) Kawasaki Y, et al. Multivariate voxel-based morphometry successfully differentiates schizophrenia patients from healthy controls. Neuroimage 2007 ; 34 : 235-242.
PubMed
Lawrie SM, Weinberger DR, Johnstone EC. Schizophrenia : From Neuroimaging To Neuroscience. Oxford : Oxford University Press ; 2004. pp1-72, 93-166.
 
笠井清登. 統合失調症脳画像研究と早期診断. 臨床精神医学 2007 ; 36 (4) : 405-408.
Medical*Online
笠井清登. 神経画像・生理指標を中間表現型とした統合失調症関連遺伝子多型との関連研究. 分子精神医学 2007 ; 7 (3) : 222-231.
 
山末英典, 笠井清登. 自動脳形態解析による統合失調症研究. 最新精神医学 2004 ; 9 (5) : 435-444.
 
山末英典, 笠井清登. 統合失調症のMRI研究. 精神科 2006 ; 9 (3) : 193-199.
 
P.79 掲載の参考文献
1) Lee KH, et al. Social cognition, brain networks and schizophrenia. Psychol Med 2004 ; 34 : 391-400.
PubMed
2) Vollm BA, et al. Neuronal correlates of theory of mind and empathy : A functional magnetic resonance imaging study in a nonverbal task. Neuroimage 2006 ; 29 : 90-98.
 
3) Hynes CA, et al. Differential role of the orbital fronta lobe in emotional versus cognitive perspective-taking. Neuropsychologia 2006 ; 44 : 374-383.
 
4) Montag C, et al. Self-reported empathic abilities in schizophrenia. Schizophr Res 2007 ; 92 : 85-89.
PubMed
5) Namiki C, et al. Impaired facial emotion recognition and reduced amygdalar volume in schizophrenia. Psychiatry Res 2007 ; 156 : 23-32.
PubMed
6) Yamada M, et al. Social cognition and frontal lobe pathology in schizophrenia : A voxel-based morphometric study. Neuroimage 2007 ; 35 : 292-298.
PubMed
7) Fujiwara H, et al. Anterior cingulate pathology and social cognition in schizophrenia : A study of gray matter, white matter and sulcal morphometry. Neuroimage 2007 ; 36 : 1236-1245.
PubMed
8) Brunet E, et al. Abnormalities of brain function during a nonverbal theory of mind task in schizophrenia. Neuropsychologia 2003 ; 41 : 1574-1582.
PubMed
9) Russell TA, et al. Exploring the social brain in schizophrenia : Left prefrontal underactivation during mental state attribution. Am J Psychiatry 2000 ; 157 : 2040-2042.
PubMed
10) Marjoram D, et al. A visual joke fMRI investigation into Theory of Mind and enhanced risk of schizophrenia. Neuroimage 2006 ; 31 : 1850-1858.
PubMed
11) Lee KH, et al. A functional magnetic resonance imaging study of social cognition in schizophrenia during an acute episode and after recovery. Am J Psychiatry 2006 ; 163 : 1926-1933.
PubMed
村井俊哉. 社会化した脳. 東京 : エクスナレッジ ; 2007.
 
特集 : Social Brain. 臨床精神医学 2007 ; 36 (8) : 939-992.
 
P.87 掲載の参考文献
1) Katon W, Sullivan MD. Depression and chronic medical illness. J Clin Psychiatry 1990 ; 51 (Suppl) : 3-11.
 
2) Spiegel D, Giese-Davis J. Depression and cancer : Mechanisms and disease progression. Biol Psychiatry 2003 ; 54 : 269-282.
PubMed
3) Schuckit MA. Trait (and state) markers of a predisposition to psychopathology. In : Michels R, et al (eds). Psychiatry. Philadelphia : JB Lippincott ; 1988. pp1-19.
 
4) Ribeiro SC, et al. The DST as a predictor of outcome in depression : A meta-analysis. Am J Psychiatry 1993 ; 150 : 1618-1629.
PubMed
5) Holsboer-Trachsler E, Stohler R, Hatzinger M. Repeated administration of the combined dexamethasone/hCRH stimulation test during treatment of depression. Psychiatry Res 1991 ; 38 : 32-38.
 
6) Watson S, et al. The dex/CRH test : Is it better than the DST? Psychoneuroendocrinology 2006 ; 31 : 889-894.
 
7) Aihara M, et al. HPA axis dysfunction in unmedicated major depressive disorder and its normalization by pharmacotherapy correlates with alteration of neural activity in prefrontal cortex and limbic/paralimbic regions. Psychiatry Res 2007 ; 155 : 245-256.
PubMed
8) van der Pompe G, Antoni MH, Heijnen CJ. Elevated basal cortisol levels and attenuated ACTH and cortisol responses to a behavioral challenge in women with metastatic breast cancer. Psychoneuroendocrinology 1996 ; 21 : 361-374.
PubMed
9) Touitou Y, et al. Disruption of the circadian patterns of serum cortisol in breast and ovarian cancer patients : Relationships with tumor marker antigens. Br J Cancer 1996 ; 74 : 1248-1252.
PubMed
10) van der Pompe G, et al. Effectiveness of a short-term group psychotherapy program on endocrine and immune function in breast cancer patients : An exploratory study. J Psychosom Res 1997 ; 42 : 453-466.
 
11) Soygur H, et al. Interleukin-6 levels and HPA axis activation in breast cancer patients with major depressive disorder. Prog Neuropsychopharmacol Biol Psychiatry 2007 ; 31 : 1242-1247.
PubMed
12) Jehn CF, et al. Biomarkers of depression in cancer patients. Cancer 2006 ; 107 : 2723-2729.
PubMed
13) Musselman DL, et al. Higher than normal plasma interleukin-6 concentrations in cancer patients with depression : Preliminary findings. Am J Psychiatry 2001 ; 158 : 1252-1257.
PubMed
14) Pace TW, Hu F, Miller AH. Cytokine-effects on glucocorticoid receptor function : Relevance to glucocorticoid resistance and the pathophysiology and treatment of major depression. Brain Behav Immun 2006 ; 21 : 9-19.
PubMed
15) Yoshikawa E, et al. Prefrontal cortex and amygdala volume in first minor or major depressive episode after cancer diagnosis. Biol Psychiatry 2006 ; 59 : 707-712.
PubMed
16) Inagaki M, et al. Regional cerebral glucose metabolism in patients with secondary depressive episodes after fatal pancreatic cancer diagnosis. J Affect Disord 2007 ; 99 : 231-236.
PubMed
17) Kumano H, et al. Brain metabolic changes associated with predispotion to onset of major depressive disorder and adjustment disorder in cancer patients : A preliminary PET study. J Psychiatr Res 2007 ; 41 : 591-599.
PubMed
山脇成人. 内富庸介 (編). サイコオンコロジー-がん医療における心の医学. 大阪 : 診療新社 ; 1997.
 
Chochinov HM, Breitbart W (編). 内富庸介 (監訳). 緩和医療における精神医学ハンドブック. 東京 : 星和書店 ; 2002.
 
倉知正佳, 松田博史 (編). 臨床精神医学講座 第S10巻 精神科臨床における画像診断. 東京 : 中山書店 ; 2000.
 
加藤忠史 (編). 甘利俊一 (監). シリーズ脳科学 6 精神の脳科学. 東京 : 東京大学出版会 ; 2008.
 
P.99 掲載の参考文献
1) Gilbertson MW, et al. Smaller hippocampal volume predicts pathologic vulnerability to psychological trauma. Nat Neurosci 2002 ; 5 : 1242-1247.
PubMed
2) Yamasue H, et al. Voxel-based analysis of MRI reveals anterior cingulate gray-matter volume reduction in posttraumatic stress disorder due to terrorism. Proc Natl Acad Sci U S A 2003 ; 100 : 9039-9043.
PubMed
3) Araki T, et al. Association between lower P300 amplitude and smaller anterior cingulate cortex volume in patients with posttraumatic stress disorder : A study of victims of Tokyo subway sarin attack. Neuroimage 2005 ; 25 : 43-50.
PubMed
4) Abe O, et al. Voxel-based diffusion tensor analysis reveals aberrant anterior cingulum integrity in posttraumatic stress disorder due to terrorism. Psychiatry Res 2006 ; 146 : 231-242.
PubMed
5) Rauch SL, et al. A symptom provocation study of posttraumatic stress disorder using positron emission tomography and script-driven imagery. Arch Gen Psychiatry 1996 ; 53 : 380-387.
PubMed
6) Lanius RA, et al. The nature of traumatic memories : A 4-T FMRI functional connectivity analysis. Am J Psychiatry 2004 ; 161 : 36-44.
PubMed
7) Pezawas L, et al. 5-HTTLPR polymorphism impacts human cingulate-amygdala interactions : A genetic susceptibility mechanism for depression. Nat Neurosci 2005 ; 8 : 828-834.
PubMed
8) Yamasue H, et al. Gender-common and-specific neuroanatomical basis of human anxietyrelated personality traits. Cereb Cortex 2008 ; 18 : 46-52.
PubMed
9) Caspi A, et al. Influence of life stress on depression : Moderation by a polymorphism in the 5-HTT gene. Science 2003 ; 301 : 386-389.
PubMed
10) Kasai K, et al. Evidence for acquired pregenual anterior cingulate gray matter loss from a twin study of combat-related posttraumatic stress disorder. Biol Psychiatry 2008 ; 63 (6) : 550-556.
PubMed
Gross C, Hen R. The developmental origins of anxiety. Nat Rev Neurosci 2004 ; 5 : 545-552.
PubMed
Smith ME. Bilateral hippocampal volume reduction in adults with post-traumatic stress disorder : A meta-analysis of structural MRI studies. Hippocampus 2005 ; 15 : 798-807.
PubMed
Herry C, Mons N. Resistance to extinction is associated with impaired immediate early gene induction in medial prefrontal cortex and amygdala. Eur J Neurosci 2004 ; 20 : 781-790.
PubMed
Phelps EA, et al. Extinction learning in humans : Role of the amygdala and vmPFC. Neuron 2004 ; 43 : 897-905.
PubMed
Gross C, et al. Serotonin1A receptor acts during development to establish normal anxiety-like behaviour in the adult. Nature 2002 ; 416 : 396-400.
PubMed
ジュデス・L・ハーマン. 中井久夫 (訳). 心的外傷と回復. 東京 : みすず書房 ; 1999.
 
岡野憲一郎. 外傷性精神障害-心の傷の病理と治療. 東京 : 岩崎学術出版 ; 1996.
 
P.110 掲載の参考文献
1) Pujol J, et al. Mapping structural brain alterations in obsessive-compulsive disorder. Arch Gen Psychiatry 2004 ; 61 : 720-730.
PubMed
2) Rosenberg DR, et al. Frontostriatal measurement in treatment-naive children with obsessivecompulsive disorder. Arch Gen Psychiatry 1997 ; 54 : 824-830.
PubMed
3) Szeszko PR, et al. White matter abnormalities in obsessive-compulsive disorder : A diffusion tensor imaging study. Arch Gen Psychiatry 2005 ; 62 : 782-790.
PubMed
4) Saxena S, et al. Cerebral metabolism in major depression and obsessive-compulsive disorder occurring separately and concurrently. Biol Psychiatry 2001 ; 50 : 159-170.
PubMed
5) Zohar J, et al. Anxiety and cerebral blood flow during behavioral challenge. Dissociation of central from peripheral and subjective measures. Arch Gen Psychiatry 1989 ; 46 : 505-510.
PubMed
6) Shapira NA, et al. Brain activation by disgust-inducing pictures in obsessive-compulsive disorde. Biol Psychiatry 2003 ; 54 : 751-756.
 
7) Benkelfat C, et al. Local cerebral glucose metabolic rates in obsessive-compulsive disorder. Patients treated with clomipramine. Arch Gen Psychiatry 1990 ; 47 : 840-848.
PubMed
8) Baxter LR, et al. Caudate glucose metabolic rate changes with both drug and behavior therapy for obsessive-compulsive disorder. Arch Gen Psychiatry 1992 ; 49 : 681-689.
PubMed
9) Nakao T, et al. Brain activation of patients with obsessive-compulsive disorder during neuropsychological and symptom provocation tasks before and after symptom improvement : A functional MRI study. Biol Psychiatry 2005 ; 57 : 901-910.
PubMed
10) Saxena S, et al. Localized orbitofrontal and subcortical metabolic changes and predictors of response to paroxetine treatment in obsessive-compulsive disorder. Neuropsychopharmacology 1999 ; 21 : 683-693.
PubMed
11) Rauch SL, et al. Predictors of fluvoxamine response in contamination-related obsessive compulsive disorder : A PET symptom provocation study. Neuropsychopharmacology 2002 ; 27 : 782-791.
PubMed
12) Hesse S, et al. Serotonin and dopamine transporter imaging in patients with obsessive-compulsive disorder. Psychiatry Res 2005 ; 140 : 63-72.
PubMed
13) Saxena S, et al. Neuroimaging and frontal-subcortical circuitry in obsessive-compulsive disorder. Br J Psychiatry 1998 ; 173 : 26-37.
 
14) Mataix-Cols D, et al. Distinct neural correlates of washing, cheking and hoarding symptom dimensions in obsessive-compulsive disorder. Arch Gen Psychiatry 2004 ; 61 : 564-576.
 
Friedlander L, Desrocher M. Neuroimaging studies of obsessive-compulsive disorder in adults and children. Clin Psychol Rev 2006 ; 26 : 32-49.
PubMed
Mataix-Cols D, Rosario-Campos MC, Leckman JF. A multidimensional model of obsessivecompulsive disorder. Am J Psychiatry 2005 ; 162 : 228-238.
PubMed
中尾智博, 中川彰子. 強迫性障害の認知機能. 精神医学 2002 ; 44 : 1044-1054.
 
高橋克朗. 強迫性障害-病因と病態生理. 田代信維, ほか (編). 臨床精神医学講座 第5巻 神経症性障害・ストレス関連障害. 東京 : 中山書店 ; 1997. pp329-361.
 
P.120 掲載の参考文献
1) Gorman JM, et al. Neuroanatomical hypothesis of panic disorder, revised. Am J Psychiatry 2000 ; 157 (4) : 493-505.
PubMed
2) Nishimura Y, et al. Frontal dysfunction during a cognitive task in drug-naive patients with panic disorder as investigated by multi-channel near-infrared spectroscopy imaging. Neurosci Res 2007 ; 59 (1) : 107-112.
PubMed
Stein DJ, Hollander E. 樋口輝彦, ほか (訳). 不安障害. 東京 : 日本評論社 ; 2005.
 
Stein DJ. 田島治, ほか (訳). 不安とうつの脳と心のメカニズム-感情と認知のニューロサイエンス. 東京 : 星和書店 ; 2007.
 
竹内龍雄 (編). 新しい診断と治療のABC40/精神 3. パニック障害. 2006年最新医学別冊. 大阪 : 最新医学社 ; 2006.
 
谷井久志, ほか. 脳神経疾患の分子病態と治療への展開. パニック障害研究の現状と展望. 実験医学 2007 ; 25 (13) : 2061-2066.
 
小嶋麻紀, 塩入俊樹, 染矢俊幸. パニック障害脳画像所見その後. 臨床精神医学 2001 ; 30 (8) : 971-980.
Medical*Online
北村秀明, 塩入俊樹. 強迫性障害およびパニック障害. 精神科治療学 2001 ; 16 (10) : 997-1002.
 
穐吉條太郎. 高次脳機能とパニック障害. 竹内龍雄, ほか (編). パニック障害 セミナー 2002. 東京 : 日本評論社 ; 2002. pp145-165.
 
P.131 掲載の参考文献
1) Guido K, et al. Neuroimaging studies in eating disorders. CNS Spectrum 2004 ; 9 : 539-548.
 
2) Frank GK, Kaye WH. Positron emission tomography studies in eating disorders : Multireceptor brain imaging, correlates with behavior and implications for pharmacotherapy. Nucl Med Biol 2005 ; 32 : 755-761.
PubMed
3) Naruo T. Brain imaging. XXIII-8. In : D'haunen H, et al (eds). Biological Psychiatry (2). Chichester : Willy and Sons ; 2002. pp1181-1187.
 
4) Kaye WH, et al. Brain imaging of serotonin after recovery from anorexia and bulimia nervosa. Physiol Behav 2005 ; 86 : 15-17.
PubMed
5) 福田正人, 三國雅彦, 心の健康に光トポグラフィー検査を応用する会. 近赤外線スペクトロスコピィNIRSによる統合失調症と感情障害の補助診断. 精神医学 2007 ; 49 : 231-243.
 
6) Barbarich-Marsteller NC, Marx R. Question and answer : Neuroimaging in the treatment of eating disorders. What is neuroimaging and how can it be used to improve the treatment of eating disorders? Eat Disord 2007 ; 15 : 273-275.
PubMed
Frank GK, et al. Regional cerebral blood flow after recovery from anorexia or bulimia nervosa. Int J Eat Disord 2007 ; 40 : 488-492.
 
Matsumoto R, et al. Regional cerebral blood flow changes associated with interoceptive awareness in the recovery process of anorexia nervosa. Prog Neuropsychopharmacol Biol Psychiatry 2006 ; 30 : 1265-1270.
PubMed
Kojima S, et al. Comparison of regional cerebral blood flow in patients with anorexia nervosa before and after weight gain. Psychiatry Res 2005 ; 140 : 251-258.
PubMed
Naruo T, et al. Characteristic regional cerebral blood flow patterns in anorexia nervosa patients with binge/purge behavior. Am J Psychiatry 2000 ; 157 : 1520-1522.
PubMed
Mahlau M, et al. Gray matter decrease of the anterior cingulate cortex in anorexia nervosa. Am J Psychiatry 2007 ; 164 : 1850-1857.
 
Wagner A, et al. Normal brain tissue volumes after long-term recovery in anorexia and bulimia nervosa. Biol Psychiatry 2006 ; 59 : 291-293.
PubMed
Wagner A, et al. Altered reward processing in women recovered from anorexia nervosa. Am J Psychiatry 2007 ; 164 : 1842-1849.
PubMed
Wagner A, et al. Altered insula response to taste stimuli in individuals recovered from restricting-type anorexia nervosa. Neuropsychopharmacology 2008 ; 33 (3) : 513-523.
PubMed
Kurosaki M, et al. Distorted images of one's own body activates the prefrontal cortex and limbic/paralimbic system in young women : A functional magnetic resonance imaging study. Biol Psychiatry 2006 ; 59 : 380-386.
PubMed
Shirao N, et al. Gender differences in brain activity generated by unpleasant word stimuli concerning body image : An fMRI study. Br J Psychiatry 2005 ; 186 : 48-53.
PubMed
Uher R, et al. Functional neuroanatomy of body shape perception in healthy and eating-disordered women. Biol Psychiatry 2005 ; 58 : 990-997.
PubMed
Suda M, et al. Frontal lobe function in eating disorder : A multichannel near-infrared spectroscopy study. Proceeding of the 37th conference of Clinical Neurophysiology. Utsunomiya, Nov 2007.
 
Uehara T, et al. Cerebral blood volume changes inpatients with eating disorders during word fluency : A preliminary study using multi-channel near infrared spectroscopy. Eat Weight Disord 2007 ; 12 : 183-190.
 
Bailer UF, et al. Exaggerated 5-HT1A but normal 5-HT2A receptor activity in individuals ill with anorexia nervosa. Biol Psychiatry 2007 ; 61 : 1090-1099.
PubMed
Bailer UF, et al. Serotonin transporter binding after recovery from eating disorders. Psychopharmacology (Berl) 2007 ; 195 : 315-324.
PubMed
P.139 掲載の参考文献
1) 橋本謙二. 薬物依存の脳画像解析と臨床遺伝学的研究. 分子精神医学 2007 ; 7 : 245-248.
Medical*Online
2) Hashimoto K. New research on methamphetamine abuse. In : Toolaney GH (ed). New Research on Methamphetamine Abuse. New York : Nova Science Publishers ; 2007. pp1-51.
 
3) Volkow ND, et al. Low level of brain dopamine D2 receptors in methamphetamine abusers : Association with metabolism in the orbitofrontal cortex. Am J Psychiatry 2001 ; 158 : 2015-2021.
PubMed
4) Volkow ND, et al. Association of dopamine transporter reduction with psychomotor impairment in methamphetamine abusers. Am J Psychiatry 2001 ; 158 : 377-382.
PubMed
5) Sekine Y, et al. Methamphetamine-related psychotic symptoms and reduced brain dopamine transporters studied with PET. Am J Psychiatry 2001 ; 158 : 1206-1214.
PubMed
6) Sekine Y, et al. Brain serotonin transporter density and aggression in abstinent methamphetamine abusers. Arch Gen Psychiatry 2006 ; 63 : 90-100.
PubMed
7) Cowan RL. Neuroimaging research in human MDMA users : A review. Psychopharmacology (Berl) 2007 ; 189 : 539-556.
PubMed
8) Doblin R. A clinical plan for MDMA (Ecstasy) in the treatment of posttraumatic stress disorder (PTSD) : Partnering with the FDA. J Psychoactive Drugs 2002 ; 34 : 185-194.
PubMed
9) Parrott AC. The psychotherapeutic potential of MDMA (3,4-methylenedioxymethamphetamine) : An evidence-based review. Psychopharmacology (Berl) 2007 ; 191 : 181-193.
PubMed
10) Heinz A, et al. Correlation of stable elevations in striatal m-opioid receptor availability in detoxified alcoholic patients with alcohol craving : A positron emission tomography study using carbon 11-labeled carfentanil. Arch Gen Psychiatry 2005 ; 62 : 57-64.
 
11) Brody AL. Functional brain imaging of tobacco use and dependence. J Psychiatric Res 2006 ; 40 : 404-418.
PubMed
12) Brody AL, et al. Gene variants of brain dopamine pathways and smoking-induced dopamine release in the ventral caudate/nucleus accumbens. Arch Gen Psychiatry 2006 ; 63 : 808-816.
PubMed
13) Brody AL, et al. Cigarette smoking saturates brain a4b2 nicotinic acetylcholine receptors. Arch Gen Psychiatry 2006 ; 63 : 907-915.
 
14) 和田清, 内村直尚, 小沼杏坪. 有機溶剤使用による精神・行動の障害. 白倉克之, ほか (編). アルコール・薬物関連障害の診断・治療ガイドライン. 東京 : じほう ; 2003. pp189-204.
 
白倉克之, 樋口進, 和田 清 (編). アルコール・薬物関連障害の診断・治療ガイドライン. 東京 : じほう ; 2003.
 
Toolaney GH (ed). New Research on Methamphetamine Abuse. New York : Nova Science Publishers ; 2007.
 
George TP (ed). Medication Treatments for Nicotine Dependence. Boca Raton : CRC Press ; 2007.
 
P.149 掲載の参考文献
1) Matsuda H, et al. Longitudinal evaluation of both morphologic and functional changes in the same individuals with Alzheimer's disease. J Nucl Med 2002 ; 43 (3) : 304-311.
PubMed
2) McPherson SE, Cummings JL. Neuropsychological aspects of vascular dementia. Brain Cogn 1996 ; 31 (2) : 269-282.
PubMed
3) Galton CJ, et al. Temporal lobe rating scale : Application to Alzheimer's disease and frontotemporal dementia. J Neurol Neurosurg Psychiatry 2001 ; 70 (2) : 165-173.
PubMed
4) Minoshima S, et al. Alzheimer's disease versus dementia with Lewy bodies : Cerebral metabolic distinction with autopsy confirmation. Ann Neurol 2001 ; 50 (3) : 358-365.
PubMed
5) Oide T, et al. Usefulness of [123I］metaiodobenzylguanidine ([123I］MIBG) myocardial scintigraphy in differentiating between Alzheimer's disease and dementia with Lewy bodies. Intern Med 2003 ; 42 (8) : 686-690.
PubMed
6) Oba H, et al. New and reliable MRI diagnosis for progressive supranuclear palsy. Neurology 2005 ; 64 (12) : 2050-2055.
PubMed
7) Hirono N, et al. Features of regional cerebral glucose metabolism abnormality in corticobasal degeneration. Dement Geriatr Cogn Disord 2000 ; 11 (3) : 139-146.
PubMed
8) Kitagaki H, et al. CSF spaces in idiopathic normal pressure hydrocephalus : Morphology and volumetry. AJNR Am J Neuroradiol 1998 ; 19 (7) : 1277-1284.
 
9) Tschampa HJ, et al. Thalamic involvement in sporadic Creutzfeldt-Jakob disease : A diffusionweighted MR imaging study. AJNR Am J Neuroradiol 2003 ; 24 (5) : 908-915.
PubMed
松田博史, 朝田隆 (編). 見て診て学ぶ痴呆の画像診断. 大阪 : 永井書店 ; 2004.
 
McKeel DW, et al. Dementia : An atlas of investigation and diagnosis. Oxford : Clinical Publishing ; 2007.
 
P.161 掲載の参考文献
1) Kanwisher N, McDermott J, Chun MM. The fusiform face area : A module in human extrastriate cortex specialized for face perception. J Neurosci 1997 ; 17 : 4302-4311.
PubMed
2) Kanwisher N, Tong F, Nakayama K. The effect of face inversion on the human fusiform face area. Cognition 1998 ; 68 : B1-11.
PubMed
3) George N, et al. Contrast polarity and face recognition in the human fusiform gyrus. Nat Neurosci 1999 ; 2 : 574-580.
PubMed
4) Puce A, et al. Temporal cortex activation in humans viewing eye and mouth movements. J Neurosci 1998 ; 18 : 2188-2199.
PubMed
5) Hoffman EA, Haxby JV. Distinct representations of eye gaze and identity in the distributed human neural system for face perception. Nat Neurosci 2000 ; 3 : 80-84.
PubMed
6) Broks P, et al. Face processing impairments after encephalitis : Amygdala damage and recognition of fear. Neuropsychologia 1998 ; 36 : 59-70.
PubMed
7) Whalen PJ, et al. A functional MRI study of human amygdala responses to facial expressions of fear versus anger. Emotion 2001 ; 1 : 70-83.
PubMed
8) Sato W, et al. The amygdala processes the emotional significance of facial expressions : An fMRI investigation using the interaction between expression and face direction. Neuroimage 2004 ; 22 : 1006-1013.
PubMed
9) Sato W, et al. Enhanced neural activity in response to dynamic facial expressions of emotion : An fMRI study. Cognitive Brain Research 2004 ; 20 : 81-91.
PubMed
10) Schultz RT, et al. Abnormal ventral temporal cortical activity during face discrimination among individuals with autism and Asperger syndrome. Arch Gen Psychiatry 2000 ; 57 : 331-340.
PubMed
11) Critchley HD, et al. The functional neuroanatomy of social behavior : Changes in cerebral blood flow when people with autistic disorder process facial expression. Brain 2000 ; 123 : 2203-2212.
PubMed
12) Pierce K, et al. Face processing occurs outside the fusiform'face area'in autism : Evidence from functional MRI. Brain 2001 ; 124 : 2059-2073.
PubMed
13) Hadjikhani N, et al. Abnormal activation of the social brain during face perception in autism. Hum Brain Mapp 2007 ; 28 : 441-449.
PubMed
14) Pierce K, et al. The brain response to personally familiar faces in autism : Findings of fusiform activity and beyond. Brain 2004 ; 127 : 2703-2716.
PubMed
15) Ashwin C, et al. Differential activation of the amygdala and the 'social brain' during fearful face-processing in Asperger Syndrome. Neuropsychologia 2007 ; 45 : 2-14.
PubMed
16) Welchew DE, et al. Functional disconnectivity of the medial temporal lobe in Asperger's syndrome. Biol Psychiatry 2005 ; 57 : 991-998.
PubMed
17) 十一元三. 広汎性発達障害と前頭葉. 臨床精神医学 2003 ; 32 : 395-404.
Medical*Online
18) Filipek PA, et al. Volumetric MRI analysis comparing subjects having attention-deficit hyperactivity disorder with normal controls. Neurology 1997 ; 48 : 589-601.
PubMed
19) Castellanos FX, et al. Quantitative brain magnetic resonance imaging in girls with attentiondeficit/hyperactivity disorder. Arch Gen Psychiatry 2001 ; 58 : 289-295.
 
20) Castellanos FX, et al. Developmental trajectories of brain volume abnormalities in children and adolescents with attention-deficit/hyperactivity disorder. JAMA 2002 ; 288 : 1740-1748.
PubMed
21) Sowell ER, et al. Cortical abnormalities in children and adolescents with attention-deficit hyperactivity disorder. Lancet 2003 ; 362 : 1699-1707.
PubMed
22) Shaw P, et al. Longitudinal mapping of cortical thickness and clinical outcome in children and adolescents with attention-deficit/hyperactivity disorder. Arch Gen Psychiatry 2006 ; 63 : 540-549.
PubMed
23) Shaw P, et al. Attention-deficit/hyperactivity disorder is characterized by a delay in cortical maturation. Proc Natl Acad Sci U S A 2007 ; 104 : 19649-19654.
PubMed
24) Plessen KJ, et al. Hippocampus and amygdale morphology in attention-deficit/hyperactivity disorder. Arch Gen Psychiatry 2006 ; 63 : 795-807.
 
25) Jucaite A, et al. Reduced midbrain dopamine transporter binding in male adolescents with attention-deficit/hyperactivity disorder : Association between striatal dopamine markers and motor hyperactivity. Biol Psychiatry 2005 ; 57 : 229-238.
PubMed
26) Volkow ND, et al. Brain dopamine transporter levels in treatment and drug naive adults with ADHD. Neuroimage 2007 ; 34 : 1182-1190.
PubMed
十一元三. 自閉症の神経基盤と脳機能. 医学のあゆみ 2006 ; 217 : 1002-1006.
Medical*Online
Rizzolatti G, Fogassi L, Gallese V. Neurophysiological mechanisms underlying the understanding and imitation of action. Nat Rev Neurosci 2001 ; 2 : 661-670.
PubMed
P.174 掲載の参考文献
1) 十束支朗. 慢性脳炎. 三好功峰, 黒田重利 (編). 臨床精神医学講座 第10巻 器質・症状性精神障害. 東京 : 中山書店 ; 1997. pp287-294.
 
2) ACR ad hoc Committee on Neuropsychiatric Lupus Nomenclature. The American college of rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. Arthritis Rheum 1999 ; 42 : 599-608.
 
3) Pamela LP. Imaging in CNS lupus. Best Prac Res Clin Rheum 2005 ; 19 : 727-739.
 
4) Darnell RB. A new cause of limbic encephalopathy. Brain 2005 ; 128 : 1745-1746.
PubMed
5) 小早川誠, 岡村仁. 悪性腫瘍の遠隔効果 "Paraneoplastic syndrome". 精神科治療学 2006 ; 21 (増) : 112-113.
 
6) 吉本博昭. チアミン (ビタミンB1) 欠乏 (ウェルニッケ・コルサコフ脳症). 精神科治療学 2006 ; 21 (増) : 195-199.
 
7) 赤井淳一郎. ビタミン欠乏症. 三好功峰, 黒田重利 (編). 臨床精神医学講座 第10巻 器質・症状性精神障害. 東京 : 中山書店 ; 1997. pp339-344.
 
8) 尾崎茂. 有機溶剤. 精神科治療学 2006 ; 21 (増) : 166-167.
 
Darnell RB, Posner JB. Paraneoplastic syndromes involving the nervous system. N Engl J Med 2003 ; 349 : 1543-1554.
PubMed
「精神科治療学」編集委員会. 症状性 (器質性) 精神障害の治療ガイドライン. 精神科治療学 2006 ; 21 (増).
 
三好功峰. 器質・症状性精神障害の特徴. 三好功峰, 黒田重利 (編). 臨床精神医学講座 第10巻 器質・症状性精神障害. 東京 : 中山書店 ; 1997. pp3-9.
 
精神医学症候群 (III) -器質・症状性精神障害など. 領域別症候群シリーズ No.40. 日本臨床. 2003 (別冊)
 
犬塚貴. Limbic encephalitis : 病因・病態と診断・治療方針. 臨床神経 2004 ; 44 : 799-801.
 
P.181 掲載の参考文献
1) 高橋英彦, 須原哲也. 精神疾患のイメージング. 日本臨牀 2007 ; 65 (2) : 336-341.
Medical*Online
2) 大久保善朗. PET. 倉知正佳, 松田博史 (編). 臨床精神医学講座 第S10巻 精神科臨床における画像診断. 東京 : 中山書店 ; 2000. pp395-409.
 
3) Yasuno F, et al. Dose relationship of limbic-cortical D2-dopamine receptor occupancy with risperidone. Psychopharmacology (Berl) 2001 ; 154 (1) : 112-114.
PubMed
4) Takano A, et al. The antipsychotic sultopride is overdosed : A PET study of drug-induced receptor occupancy in comparison with sulpiride. Int J Neuropsychopharmacol 2006 ; 9 (5) : 539-545.
PubMed
5) Takano A, et al. Estimation of the time-course of dopamine D2 receptor occupancy in living human brain from plasma pharmacokinetics of antipsychotics. Int J Neuropsychopharmacol 2004 ; 7 (1) : 19-26.
 
6) Suhara T, et al. High levels of serotonin transporter occupancy with low-dose clomipramine in comparative occupancy study with fluvoxamine using positron emission tomography. Arch Gen Psychiatry 2003 ; 60 (4) : 386-391.
PubMed
7) Suhara T, et al. Decreased dopamine D2 receptor binding in the anterior cingulate cortex in schizophrenia. Arch Gen Psychiatry 2002 ; 59 (1) : 25-30.
PubMed
8) Okubo Y, et al. Decreased prefrontal dopamine D1 receptors in schizophrenia revealed by PET. Nature 1997 ; 385 (6617) : 634-636.
PubMed
高野晶寛, 須原哲也. PET研究により統合失調症はどこまで解明されたか? 日薬理誌 2006 ; 128 : 177-183.
Medical*Online
松本良平, 須原哲也. PET によるセロトニントランスポーターのイメージングから見たうつ病の病態と治療. 日薬理誌 2007 ; 130 : 466-470.
 
須原哲也. 分子イメージングによる精神科薬物療法のエビデンス. 精神経誌 2007 ; 109 (9) : 869-875.
 
高野晴成, ほか. 薬物と動態-中枢作用薬のPETによる評価. 臨床薬理 2007 ; 38 (3) : 145-147.
 
高野晴成, 須原哲也. Positron Emission Tomography (PET) とは-医薬品開発への応用. 薬剤学 2007 ; 67 (1) : 41-45.
Medical*Online
高橋英彦, 須原哲也. ニコチン依存の分子イメージング. 細胞 2008 ; 40 (4) : 25-27.
 
P.189 掲載の参考文献
1) Glahn DC, Thompson PM, Blangero J. Neuroimaging endophenotypes : Strategies for finding genes influencing brain structure and function. Hum Brain Mapp 2007 ; 28 (6) : 488-501.
PubMed
2) Thompson PM, et al. Genetic influences on brain structure. Nat Neurosci 2001 ; 4 (12) : 1253-1258.
PubMed
3) Nemoto K, et al. The Val66Met polymorphism of the brain-derived neurotrophic factor gene affects age-related brain morphology. Neurosci Lett 2006 ; 397 (1-2) : 25-29.
 
4) Ohnishi T, et al. The association between the Val158Met polymorphism of the catechol-Omethyl transferase gene and morphological abnormalities of the brain in chronic schizophrenia. Brain 2006 ; 129 (Pt 2) : 399-410.
 
5) Meyer-Lindenberg A, et al. Impact of complex genetic variation in COMT on human brain function. Mol Psychiatry 2006 ; 11 (9) : 867-877, 797.
PubMed
6) St Clair D, et al. Association within a family of a balanced autosomal translocation with major mental illness. Lancet 1990 ; 336 (8706) : 13-16.
PubMed
7) Millar JK, et al. Disruption of two novel genes by a translocation co-segregating with schizophrenia. Hum Mol Genet 2000 ; 9 (9) : 1415-1423.
PubMed
8) Mackie S, Millar JK, Porteous DJ. Role of DISC1 in neural development and schizophrenia. Curr Opin Neurobiol 2007 ; 17 (1) : 95-102.
PubMed
9) Callicott JH, et al. Variation in DISC1 affects hippocampal structure and function and increases risk for schizophrenia. Proc Natl Acad Sci U S A 2005 ; 102 (24) : 8627-8632.
PubMed
10) Hashimoto R, et al. Impact of the DISC1 Ser704Cys polymorphism on risk for major depression, brain morphology and ERK signaling. Hum Mol Genet 2006 ; 15 (20) : 3024-3033.
PubMed
Yamasue H, Suga M, Kasai K. Investigating endophenotype of endogeneous psychotic disorders. Nihon Shinkei Seishin Yakurigaku Zasshi 2007 ; 27 (3) : 85-90.
PubMed
特集 精神疾患の脳画像解析学と分子生物学の統合. 分子精神医学 2007 ; 7 : 214-253.
 

III 脳画像検査の実用化

P.203 掲載の参考文献
1) Shenton ME, et al. A review of MRI findings in schizophrenia. Schizophr Res 2001 ; 49 : 1-52.
PubMed
2) Suzuki M, et al. Regional changes in brain gray and white matter in patients with schizophrenia demonstrated with voxel-based analysis of MRI. Schizophr Res 2002 ; 55 : 41-54.
PubMed
3) Pantelis C, et al. Structural brain imaging evidence for multiple pathological processes at different stages of brain development in schizophrenia. Schizophr Bull 2005 ; 31 : 672-696.
PubMed
4) Suzuki M, et al. Differential contributions of prefrontal and temporolimbic pathology to mechanisms of psychosis. Brain 2005 ; 128 : 2109-2122.
PubMed
5) Antonova E, et al. The relationship between brain structure and neurocognition in schizophrenia : A selective review. Schizophr Res 2004 ; 70 : 117-145.
PubMed
6) Davidson LL, Heinrichs RW. Quantification of frontal and temporal lobe brain-imaging findings in schizophrenia : A meta analysis. Psychiatry Res Neuroimaging 2003 ; 122 : 69-87.
 
7) Nakamura K, et al. Multiple structural brain measures obtained by three-dimensional MRI to distinguish between schizophrenia patients and normal subjects. Schizophr Bull 2004 ; 30 : 393-404.
PubMed
8) Kawasaki Y, et al. Multivariate voxel-based morphometry successfully differentiates schizophrenia patients from healthy controls. Neuroimage 2007 ; 34 : 235-242.
PubMed
9) Davatzikos C, et al. Whole-brain morphometric study of schizophrenia revealing a spatially complex set of focal abnormalities. Arch Gen Psychiatry 2005 ; 62 : 1218-1227.
PubMed
鈴木道雄, ほか. 統合失調症脳の構造的変化. 臨床精神薬理 2004 ; 7 : 321-330.
 
月本洋, ほか. 脳機能画像解析入門. 東京 : 医歯薬出版 ; 2007.
 
福田正人, ほか. 脳画像・神経生理指標による統合失調症の認知機能障害の評価. Schizophrenia Frontier 2006 ; 7 : 238-246.
Medical*Online
菊山裕貴, ほか. 第2世代抗精神病薬の神経保護作用を生かした新しい統合失調症の治療戦略について. 臨床精神薬理 2007 ; 6 : 1023-1033.
 
P.215 掲載の参考文献
1) Neumeister A, et al. Reduced hippocampal volume in unmedicated, remitted patients with major depression versus control subjects. Biol Psychiatry 2005 ; 57 : 935-937.
PubMed
2) Caetano SC, et al. Smaller cingulate volumes in unipolar depressed patients. Biol Psychiatry 2006 ; 59 : 702-706.
PubMed
3) Aihara M, et al. HPA axis dysfunction in unmedicated major depressive disorder and its normalization by pharmacotherapy correlates with alteration of neural activity in prefrontal cortex and limbic/paralimbic regions. Psychiatry Res : Neuroimaging 2007 ; 155 : 245-256.
 
4) Rajkowska G, Halaris A, Selemon LD. Reductions in neuronal and glial density characterize the dorsolateral prefrontal cortex in bipolar disorder. Biol Psychiatry 2001 ; 49 : 741-752.
PubMed
5) Harrison PJ. The neuropathology of primary mood disorder. Brain 2002 ; 125 : 1428-1449.
PubMed
6) Takahashi K, et al. Relationship between age at onset and magnetic resonance image-defined hyperintensities in mood disorders. J Psychiat Res 2008 ; 42 : 443-450.
PubMed
7) Fujikawa T, Yamawaki S, Touhouda Y. Incidence of silent cerebral infarction in patients with major depression. Stroke 1993 ; 24 : 1631-1634.
PubMed
8) Kumano H, et al. Brain metabolic changes associated with predispotion to onset of major depressive disorder and adjustment disorder in cancer patients-A preliminary PET study. J Psychiat Res 2007 ; 41 : 591-599.
PubMed
9) Alexopoulos GS, et al. 'Vascular depression' hypothesis. Arch Gen Psychiatry 1997 ; 54 : 915-922.
PubMed
10) Holsboer F, et al. Serial assessment of corticotropin-releasing hormone response after dexamethasone in depression. Implications for pathophysiology of DST nonsuppression. Biol Psychiatry 1987 ; 22 : 228-234.
PubMed
11) Harvey SA, Black KJ. The dexamethasone suppression test for diagnosing depression in stroke patients. Ann Clin Psychiatry 1996 ; 8 : 35-39.
PubMed
12) Sakai T, et al. Changes in density of calcium-binding-protein-immunoreactive GABAergic neurons in prefrontal cortex in schizophrenia and bipolar disorder. Neuropathology 2008 ; 28 : 143-150.
PubMed
13) Delgado PL, et al. Rapid serotonindepletion as a provocative challenge test for patients with major depression. Relevance to antidepressant action and the neurobiology of depression. Psychopharmacol Bull 1991 ; 27 : 321-330.
 
14) Rosa-Neto P, et al. Measurement of brain regional alpha-{11C} methyl-L-tryptophan trapping as a measure of serotonin synthesis in medication-free patients with major depression. Arch Gen Psychiatry 2004 ; 61 : 556-563.
PubMed
15) Muller N, Schwarz MJ. The immune-mediated alteration of serotonin and glutamate : Towards an integrated view of depression. Mol Psychiatry 2007 ; 12 : 988-1000.
PubMed
16) Takahashi K, et al. Novel augmentation therapy with cilostazol for the geriatric major depressive disorder patient with deep white matter hyperintensities on T2-weighted brain MRI : A case report. Pharmacopsychiatry 2008 ; 41 : 37-39.
PubMed
17) Baba H, et al. Seven cases of late-life depression treated with cilostazol-augmented therapy. J Clin Psychopharmacol 2007 ; 27 : 727-728.
PubMed
18) Mochizuki Y, Oishi M, Mizutani T. Effects of cilostazol on cerebral blood flow, P300, and serum lipid levels in the chronic stage of cerebral infarction. J Stroke Cerebrovasc Dis 2001 ; 10 : 63-69.
PubMed
19) Watanabe T, et al. Cilostazol protects against brain white matter damage and cognitive impairment in a rat model of chronic cerebral hypoperfusion. Stroke 2006 ; 37 : 1539-1545.
 
20) Mendlewicz J, et al. Shortened onset of action of antidepressants in major depression using acetylsalicylic acid augmentation : A pilot open-label study. Int Clin Psychopharmacol 2006 ; 21 : 227-231.
PubMed
P.226 掲載の参考文献
1) Delacourte A, et al. The biochemical pathway of neurofibrillary degeneration in aging and Alzheimer's disease. Neurology 1999 ; 52 : 1158-1165.
PubMed
2) Matsuda H. Role of neuroimaging in Alzheimer's disease, with emphasis on brain perfusion SPECT. J Nucl Med 2007 ; 48 : 1289-1300.
PubMed
3) 根本清貴, ほか. アルツハイマー型痴呆の脳血流SPECT による短期予後予測. 核医学 2004 ; 41 (3) : 347.
 
4) Matsuda H, et al. Automated discrimination between very early Alzheimer disease and controls using an easy Z-score imaging system for multicenter brain perfusion single-photon emission tomography. AJNR Am J Neuroradiol 2007 ; 28 : 731-736.
PubMed
5) Kemp PM, Holmes C. Imaging in dementia with Lewy bodies : A review. Nucl Med Commun 2007 ; 28 : 511-519.
PubMed
6) Nagata K, et al. Clinical diagnosis of vascular dementia. J Neurol Sci 2007 ; 257 : 44-48.
PubMed
松田博史, 朝田隆 (編). 見て診て学ぶ痴呆の画像診断. 大阪 : 永井書店 ; 2004.
 
P.240 掲載の参考文献
1) 福田正人, ほか. 近赤外線スペクトロスコピーによる脳機能イメージング. 臨床精神医学 2001 ; 30 : 937-951.
Medical*Online
2) 加藤忠史. MRSおよびNIRS. 倉知正佳, 松田博史 (編). 臨床精神医学講座 第S10巻 精神科臨床における画像診断. 東京 : 中山書店 ; 2000. pp498-510.
 
3) 小泉英明. 光トポグラフィ. 臨床精神医学講座 第S10巻 精神科臨床における画像診断. 東京 : 中山書店 ; 2000. pp126-134.
 
4) 福田正人, ほか. 精神疾患の生理学におけるNIRSの意義. 臨床精神医学 2004 ; 33 : 787-798.
Medical*Online
5) 福田正人, ほか. NIRS. 臨床精神医学 増刊号 特集/精神科臨床評価・検査法マニュアル. 2004 ; 33 : 584-588.
 
6) 福田正人, 三國雅彦, 心の健康に光トポグラフィー検査を応用する会. 近赤外線スペクトロスコピィNIRSによる統合失調症と感情障害の補助診断. 精神医学 2007 ; 49 : 231-243.
 
7) Suto T, et al. Multichannel near-infrared spectroscopy in depression and schizophrenia : Cognitive brain activation study. Biol Psychiatry 2004 ; 55 : 501-511.
PubMed
8) Kameyama M, et al. Frontal lobe function in bipolar disorder : A multichannel near-infrared spectroscopy study. NeuroImage 2006 ; 29 : 172-184.
PubMed
9) 福田正人, 丹羽真一. 診断 : 生物学的マーカーの利用可能性. 中根允文, 小山司 (編). 臨床精神医学講座 第2巻 精神分裂病I. 東京 : 中山書店 ; 1999. pp441-462.
 
日本脳代謝モニタリング研究会. 臨床医のための近赤外分光法. 東京 : 新興医学出版社 ; 2002.
 
Strangman G, Boas DA, Sutton JP. Non-invasive neuroimaging using near-infrared light. Biol Psychiatry 2002 ; 52 : 679-693.
PubMed
特集「NIRSによる機能画像の新展開」. 臨床精神医学 2004 ; 33 (6).
 
特集「光脳機能計測の臨床応用」. 認知神経科学 2007 ; 9 (3).
 
Yamasue H, et al. Using advanced neuroimaging techniques toward understanding schizophrenia. In : Pletson JE (ed). Psychology and Schizophrenia. NY : Nova Science Publishers ; 2007. pp41-81.
 

書評

最近チェックした商品履歴

Loading...